SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma Advanced Research Company informs about board meeting

26 Jul 2017 Evaluate

Pursuant to regulation 29 (1) of the SEBI (Listing obligation & Disclosure Requirements) Regulation, 2015, Sun Pharma Advanced Research Company has informed that a meeting of the Board of Directors of the Company will be held on Saturday, 5th August, 2017, to consider and take on record, the unaudited financial results of the Company for the quarter ended 30th June 2017. Further, kindly note that pursuant to the Company’s Code of Internal Procedures and Code of Conduct for Prevention of Insider Trading, the trading window for trading by designated persons shall be closed from Thursday, 27th July 2017 to Tuesday, 8th August, 2017.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

145.50 0.95 (0.66%)
21-Apr-2026 11:13 View Price Chart
Peers
Company Name CMP
Syngene Internation. 449.20
Indegene 484.60
CMS Info Systems 318.55
JITF Infralogistics 324.65
Sagility 42.89
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×